M
Elixir Phenomen · Sweden
CERTIFICATE OF ANALYSIS
ISO/IEC 17025 · GMP-aligned · For research use only
Document №
COA-EP-44894-O
Issued
2026-06-12
Product name
Tirzepatide
Category
Metabolism
CAS №
2023788-19-2
Molecular weight
4813.5 g/mol
Quantity / Vial
10 mg
Appearance
White lyophilized powder
Batch №
EP-44894-O
Lot
L8894
Date of analysis
2026-06-08
Expiry (lyophilized, −20 °C)
2029-06-12
Analytical Results
| Test | Method | Specification | Result | Pass |
|---|---|---|---|---|
| Purity | RP-HPLC | ≥ 99% | 99.13 % | ✓ |
| Identity | ESI-MS | Matches theoretical mass | 99.53 % match | ✓ |
| Water content | Karl Fischer | ≤ 6.0 % | 1.58 % | ✓ |
| Acetate content | Ion chromatography | ≤ 12.0 % | 5.94 % | ✓ |
| Endotoxin | LAL kinetic | ≤ 1.0 EU/mg | 0.246 EU/mg | ✓ |
| Bioburden | Plate count | ≤ 100 CFU/g | < 10 CFU/g | ✓ |
| Appearance | Visual | White powder | Conforms | ✓ |
| Solubility | Bacteriostatic water | Clear, colourless | Conforms | ✓ |
Research scope
Category
Metabolism
Reference note
Dubbel GIP/GLP-1 receptoragonist.
Batch EP-44894-O har testats enligt intern SOP-PEP-002 och uppfyller samtliga release-specifikationer ovan. Lagras lyofiliserad vid −20 °C, skyddad från ljus. Endast för laboratorieforskning. Ej för humant eller veterinärt bruk.
Analyzed & released by
Assam
Assam
Senior Analytical Chemist · QA Release
Testing laboratory
Malmö Intelligent Lab Analysis
Andrés Bello 2425
Providencia, Santiago
Chile
Providencia, Santiago
Chile
Lab ID: MILA-CL-2018-PEP
CERTIFIED
M·I·L·A
2026-06-08